特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
951415

眼科用機器の世界市場:製品機能別の機会分析と業界予測:2020年~2027年

Ophthalmic Devices Market by Product Function : Global Opportunity Analysis and Industry Forecast, 2020-2027

出版日: | 発行: Allied Market Research | ページ情報: 英文 175 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.60円
眼科用機器の世界市場:製品機能別の機会分析と業界予測:2020年~2027年
出版日: 2020年06月01日
発行: Allied Market Research
ページ情報: 英文 175 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の眼科用機器市場は、2019年の325億3,400万米ドルから2027年には448億6,500万米ドルに達すると予測されており、2020年から2027年までのCAGRは4.0%になる見通しです。眼科用機器は、眼疾患の診断、手術、視力矯正のために設計された医療機器であり、緑内障、白内障、視力関連の問題など、さまざまな眼疾患の有病率の増加に伴って重要性が高まっています。市場拡大の原動力となるのは、やスマートフォンやコンピューターなどのデジタル機器の普及拡大に伴う眼疾患の有病率上昇、眼内レンズ(IOL)など眼科用機器の急速な技術的進歩などの要因です。またスタッフのスキルの向上に役立つ眼科用機器使用のトレーニングと教育への注目も高まっています。

当レポートは、世界の眼科用機器市場を調査したもので、市場の概要、製品の機能別、地域別の分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

  • 市場の定義と範囲
  • 主な調査結果
  • 市場力学
    • 成長促進要因
      • 世界的な眼疾患の有病率上昇
      • 急速な技術の進歩
      • スタッフのトレーニングと教育への関心の高まり
      • 世界的なデジタルデバイス普及
    • 成長阻害要因
      • 眼関連疾患についての意識の低さ
      • 熟練した専門家の不足
    • 市場機会
      • 眼科用機器メーカーの新興国における潜在的な成長機会
  • 政府の規制
    • FDA
    • CEマーク
    • 医薬品医療機器総合機構と厚生労働省

第4章 市場分析:製品機能別

  • 概要
    • 市場規模と予測
  • 手術用機器
    • 緑内障手術器具
    • 白内障手術器具
    • 硝子体網膜手術器具
  • 診断装置
    • 屈折器
    • 角膜トポグラフィーシステム
    • 網膜超音波システム
    • 眼底カメラ
    • 検眼鏡
    • 光干渉断層計システム
    • 視野計
    • スリットランプ
    • 眼圧計
  • ビジョンケア機器
    • コンタクトレンズ
    • 眼鏡レンズ

第5章 市場分析:地域別

  • 概要
    • 市場規模と予測
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他
  • アジア太平洋
    • 日本
    • 中国
    • オーストラリア
    • インド
    • その他
  • ラテンアメリカ・中東・アフリカ
    • ブラジル
    • サウジアラビアの市場規模と予測
    • 南アフリカ
    • その他

第6章 企業プロファイル

  • Carl Zeiss Meditec AG
  • Essilor International S.A.
  • Haag-Streit holding Ag
  • Hoya Corporation
  • Johnson & Johnson
  • NIDEK CO., LTD.
  • Novartis AG (ALCON-a division of Novartis)
  • Topcon Corporation
  • Bausch Health Companies Inc.
  • Ziemer Ophthalmic Systems AG
  • List of mergers and acquisitions (M&A) activities
図表

LIST OF TABLES

  • TABLE 01. GLOBAL OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 02. OPHTHALMIC SURGICAL DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 03. OPHTHALMIC DIAGNOSTIC DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 04. OPHTHALMIC VISION CARE DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 05. OPHTHALMIC DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 06. NORTH AMERICA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 07. NORTH AMERICA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 08. U.S. OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 09. CANADA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 10. MEXICO OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 11. EUROPE OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 12. EUROPE OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 13. GERMANY OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 14. FRANCE OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 15. UK OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 16. ITALY OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 17. SPAIN OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 18. REST OF EUROPE OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 19. ASIA-PACIFIC OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 20. ASIA-PACIFIC OPHTHALMIC DEVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 21. JAPAN OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 22. CHINA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 23. AUSTRALIA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 24. INDIA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 25. REST OF ASIA-PACIFIC OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 26. LAMEA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 27. LAMEA OPHTHALMIC DEVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 28. BRAZIL OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 29. SAUDI ARABIA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 30. SOUTH AFRICA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 31. REST OF LAMEA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019-2027 ($MILLION)
  • TABLE 32. CARL ZEISS: COMPANY SNAPSHOT
  • TABLE 33. CARL ZEISS: OPERATING SEGMENTS
  • TABLE 34. CARL ZEISS: PRODUCT PORTFOLIO
  • TABLE 35. ESSILOR: COMPANY SNAPSHOT
  • TABLE 36. ESSILOR: OPERATING SEGMENTS
  • TABLE 37. ESSILOR: PRODUCT PORTFOLIO
  • TABLE 38. HAAG-STREIT: COMPANY SNAPSHOT
  • TABLE 39. HAAG-STREIT: OPERATING SEGMENTS
  • TABLE 40. HOYA: COMPANY SNAPSHOT
  • TABLE 41. HOYA: OPERATING SEGMENTS
  • TABLE 42. J&J: COMPANY SNAPSHOT
  • TABLE 43. J&J: OPERATING SEGMENTS
  • TABLE 44. J&J: PRODUCT PORTFOLIO
  • TABLE 45. NIDEK: COMPANY SNAPSHOT
  • TABLE 46. NIDEK: OPERATING SEGMENTS
  • TABLE 47. NOVARTIS: COMPANY SNAPSHOT
  • TABLE 48. NOVARTIS: OPERATING SEGMENTS
  • TABLE 49. NOVARTIS: PRODUCT PORTFOLIO
  • TABLE 50. TOPCON: COMPANY SNAPSHOT
  • TABLE 51. TOPCON: OPERATING SEGMENTS
  • TABLE 52. TOPCON: PRODUCT PORTFOLIO
  • TABLE 53. BAUSCH HEALTH COMPANIES: COMPANY SNAPSHOT
  • TABLE 54. BAUSCH HEALTH COMPANIES : OPERATING SEGMENTS
  • TABLE 55. BAUSCH HEALTH COMPANIES: PRODUCT PORTFOLIO
  • TABLE 56. ZEIMER: COMPANY SNAPSHOT
  • TABLE 57. ZIEMER: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. GLOBAL OPHTHALMIC DEVICES MARKET SEGMENTATION
  • FIGURE 02. TOP WINNING STRATEGIES, BY YEAR, 2016-2020
  • FIGURE 03. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2016-2020 (%)
  • FIGURE 04. TOP WINNING STRATEGIES, BY COMPANY, 2016-2020
  • FIGURE 05. TOP PLAYER POSITIONING, 2019
  • FIGURE 06. HIGH BARGAINING POWER OF SUPPLIERS
  • FIGURE 07. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 08. HIGH THREAT OF SUBSTITUTION
  • FIGURE 09. HIGH THREAT OF NEW ENTRANTS
  • FIGURE 10. MODERATE COMPETITVE RIVARLY
  • FIGURE 11. MARKET DYNAMICS FOR OPHTHALMIC DEVICES MARKET
  • FIGURE 12. GLOBAL REFRACTIVE ERROR SURGERY DEVICES MARKET, 2019-2027
  • FIGURE 13. GLOBAL GLAUCOMA SURGICAL DEVICES MARKET, 2019-2027
  • FIGURE 14. GLOBAL CATARACT SURGERY DEVICES MARKET, 2019-2027
  • FIGURE 15. GLOBAL VITREORETINAL EYE SURGERY DEVICES MARKET, 2019-2027
  • FIGURE 16. GLOBAL REFRACTORS MARKET, 2019-2027 ($MILLION)
  • FIGURE 17. GLOBAL CORNEAL TOPOGRAPHY SYSTEMS MARKET, 2019-2027 ($MILLION)
  • FIGURE 18. GLOBAL RETINAL ULTRASOUND SYSTEMS MARKET, 2019-2027 ($MILLION)
  • FIGURE 19. GLOBAL FUNDUS CAMERA MARKET, 2019-2027 ($MILLION)
  • FIGURE 20. GLOBAL OPHTHALMOSCOPES MARKET, 2019-2027 ($MILLION)
  • FIGURE 21. GLOBAL OPTICAL COHERANCE TOMPGRAPHY SYSTEMS MARKET, 2019-2027 ($MILLION)
  • FIGURE 22. GLOBAL PERIMETERS MARKET, 2019-2027 ($MILLION)
  • FIGURE 23. GLOBAL SLIT LAMPS MARKET, 2019-2027 ($MILLION)
  • FIGURE 24. GLOBAL TONOMETERS MARKET, 2019-2027 ($MILLION)
  • FIGURE 25. GLOBAL CONTACT LENSES MARKET, 2019-2027 ($MILLION)
  • FIGURE 26. GLOBAL SPECTACLE LENSES MARKET, 2019-2027 ($MILLION)
  • FIGURE 27. U.S. OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 28. CANADA OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 29. MEXICO OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 30. GERMANY OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 31. FRANCE OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 32. UK OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 33. ITALY OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 34. SPAIN OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 35. REST OF THE EUROPE OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 36. JAPAN OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 37. CHINA OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 38. AUSTRALIA OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 39. INDIA OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 40. REST OF ASIA-PACIFIC OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 41. BRAZIL OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 42. SAUDI ARABIA OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 43. SOUTH AFRICA OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 44. REST OF LAMEA OPHTHALMIC DEVICES MARKET, 2019-2027 ($MILLION)
  • FIGURE 45. CARL ZEISS: REVENUE, 2017-2019 ($MILLION)
  • FIGURE 46. CARL ZEISS: REVENUE SHARE BY SEGMENT, 2019 (%)
  • FIGURE 47. CARL ZEISS: REVENUE SHARE BY REGION, 2019 (%)
  • FIGURE 48. ESSILOR: REVENUE, 2017-2019 ($MILLION)
  • FIGURE 49. ESSILOR: REVENUE SHARE BY SEGMENT, 2019 (%)
  • FIGURE 50. HOYA: REVENUE, 2017-2019 ($MILLION)
  • FIGURE 51. HOYA: REVENUE SHARE BY SEGMENT, 2019 (%)
  • FIGURE 52. HOYA: REVENUE SAHRE FOR LIFE CARE SEGMENT, 2019 (%)
  • FIGURE 53. HOYA: REVENUE SHARE BY REGION, 2019 (%)
  • FIGURE 54. J&J: REVENUE, 2017-2019 ($MILLION)
  • FIGURE 55. J&J: REVENUE SHARE BY SEGMENT, 2019 (%)
  • FIGURE 56. J&J: REVENUE SHARE BY REGION, 2019 (%)
  • FIGURE 57. NOVARTIS: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 58. NOVARTIS: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 59. NOVARTIS: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 60. TOPCON: REVENUE, 2016-2018 ($MILLION)
  • FIGURE 61. TOPCON: REVENUE SHARE BY SEGMENT, 2018 (%)
  • FIGURE 62. BAUSCH HEALTH COMPANIES : REVENUE, 2017-2019 ($MILLION)
  • FIGURE 63. BAUSCH HEALTH COMPANIES : REVENUE SHARE BY SEGMENT, 2019 (%)
  • FIGURE 64. BAUSCH HEALTH COMPANIES : REVENUE SHARE BY REGION, 2019 (%)
目次
Product Code: A01716

Title:
Ophthalmic Devices Market by Product Function [Surgical Devices (Refractive Error Surgery Devices, Glaucoma Surgery Devices, Cataract Surgery Devices, and Vitreoretinal Surgery Devices) Ophthalmic Diagnostic Devices (Refractors, Corneal Topography Systems, Retinal Ultrasound Systems, Fundus Camera, Ophthalmoscopes, OCT, Perimeters, Slit Lamps, and Tonometer), and Vision Care Devices (Contact Lenses and Spectacles)]: Global Opportunity Analysis and Industry Forecast, 2020-2027.

The global ophthalmic devices market was valued at $32,534.0 million in 2019, and is projected to reach $44,865.0 million by 2027, registering a CAGR of 4.0 % from 2020 to 2027.

Ophthalmology is a branch of medical science that deals with the structure, function, and various eye diseases. Ophthalmic devices are medical equipment designed for diagnosis, surgery, and vision correction. These devices are gaining increased importance and adoption due to surge in prevalence of various ophthalmic diseases such as glaucoma, cataract, and other vision-related issues.

The growth of the global ophthalmic devices market is majorly driven by rise in adoption of digital devices, including laptops, smartphones, and computers, e-readers; rapid technological advancements in ophthalmic devices such as intraocular lenses (IOLs) coupled with increasing focus on customer training and education for the use of ophthalmic devices which would help in building the staff skills; and surge in awareness related to devices used in ophthalmology. However, low awareness regarding eye-related diseases and dearth of skilled professionals are expected to hamper the growth of the market. Also, emerging countries such as China, India and other Asia-Pacific countries possess high growth potential, owing to the improving healthcare infrastructures in these countries.

Based on product function, the report segments the global ophthalmic devices market into ophthalmic surgical devices, diagnostic devices, and vision care devices. The ophthalmic surgical devices segment is further categorized into refractive error surgical devices, glaucoma surgical devices, cataract surgical devices, and vitreoretinal surgical devices. The cataract surgery devices segment dominated the ophthalmic surgical devices market in 2019, and is expected to reach $5,219.6 by 2017, registering a CAGR of 3.9% from 2020 to 2027.

The ophthalmic diagnostic devices segment is sub segmented into refractors, corneal topography systems, retinal ultrasound systems, fundus camera, ophthalmoscopes, optical coherence tomography systems, perimeters, slit lamps, and tonometer. The retinal ultrasound segment is expected to reach $3,286.6 by 2027, registering a CAGR of 4.4% from 2020 to 2027.

The vision care devices segment is bifurcated into contact lenses and spectacle lenses. The spectacle leases segment is expected to reach $12,669 by 2027, registering a CAGR of 3.6% from 2020 to 2027.

On a regional level, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The North America ophthalmic devices market accounted for the largest share; however, the Asia-Pacific region is anticipated to grow with the highest CAGR of 4.5% during the forecast period.

The global ophthalmology devices market is highly competitive in nature, as major players have focused on the development and launch of innovative products to garner maximum share in the competitive market. The key players operating in the market include Abbott Laboratories, Novartis AG, Carl Zeiss Meditec AG, Essilor International S.A., HAAG-Streit Holding AG, Johnson & Johnson, Nidek Co., Ltd., Topcon Corporation, Valeant Pharmaceuticals International, Inc., and Ziemer Ophthalmic Systems AG. The other players in the industry include Sonomed Escalon, Hoya Group, Gulden Ophthalmics, FCI Ophthalmics, Glaukos Corporation, and STAAR Surgical.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the global ophthalmic devices market size along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers market analysis from 2020 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
  • A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global ophthalmic devices market growth.

KEY MARKET SEGMENTS

By Product Function

  • Ophthalmic Surgical Devices
  • Refractive Error Surgical Devices
  • Glaucoma Surgical Devices
  • Cataract Surgery Devices
  • Vitreoretinal Surgical Devices
  • Ophthalmic Diagnostic Devices
  • Refractors
  • Corneal Topography Systems
  • Retinal Ultrasound Systems
  • Fundus Camera
  • Ophthalmoscopes
  • Optical Coherence Tomography Systems
  • Perimeters
  • Slit Lamps
  • Tonometer's
  • Ophthalmic Vision Care Devices
  • Contact Lenses
  • Spectacle Lenses

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA
  • List of key players profiled in the report
  • Novartis AG
  • Carl Zeiss Meditec AG
  • Essilor International S.A.
  • HAAG-Streit Holding AG
  • Johnson & Johnson
  • Nidek Co., Ltd.
  • Topcon Corporation
  • Valeant Pharmaceuticals International, Inc.
  • Ziemer Ophthalmic Systems AG
  • Hoya Corporation

List of other players in the value chain (profiles not included in the report):

  • Sonomed Escalon
  • Gulden Ophthalmics
  • FCI Ophthalmics
  • Glaukos Corporation
  • STAAR Surgical GE Healthcare (U.K.)

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
    • 1.1.1. Key benefits for stakeholders
    • 1.1.2. Key market segments
  • 1.2. Research methodology
    • 1.2.1. Secondary research
    • 1.2.2. Primary research
    • 1.2.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. MARKET DEFINITION AND SCOPE
  • 3.2. KEY FINDINGS
    • 3.2.1. Top winning strategies
    • 3.2.2. Top player positioning, 2019
    • 3.2.3. Key forces shaping the global ophthalmic devices market
  • 3.3. MARKET DYNAMICS
    • 3.3.1. Drivers
      • 3.3.1.1. Rise in prevalence of eye-related diseases worldwide
      • 3.3.1.2. Rapid technological advancements in ophthalmic
      • 3.3.1.3. Increase in focus on customer training and education along with awareness
      • 3.3.1.4. High adoption of digital devices worldwide
    • 3.3.2. Restraints
      • 3.3.2.1. Low awareness about eye-related diseases
      • 3.3.2.2. Dearth of skilled professionals53
    • 3.3.3. Opportunities
      • 3.3.3.1. Potential growth opportunities in emerging nations for ophthalmic devices manufacturers
  • 3.4. GOVERNMENT REGULATIONS
    • 3.4.1. FDA
    • 3.4.2. CE Mark
    • 3.4.3. Pharmaceuticals and Medical Devices Agency and Ministry of Health, Labor, and Welfare (MHLW)

CHAPTER 4: OPTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION

  • 4.1. Overview
    • 4.1.1. Market size and forecast, by region
  • 4.2. Surgical devices
    • 4.2.1. Key market trends, growth factors, and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Refractive error surgical devices
      • 4.2.3.1. Market size and forecast
    • 4.2.4. Glaucoma surgical devices
      • 4.2.4.1. Market size and forecast
    • 4.2.5. Cataract surgical devices
      • 4.2.5.1. Market size and forecast
    • 4.2.6. Vitreoretinal surgical devices
      • 4.2.6.1. Market size and forecast
  • 4.3. Diagnostic devices
    • 4.3.1. Key market trends, growth factors, and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Refractors
      • 4.3.3.1. Market size and forecast
    • 4.3.4. Corneal topography systems
      • 4.3.4.1. Market size and forecast
    • 4.3.5. Retinal ultrasound systems
      • 4.3.5.1. Market size and forecast
    • 4.3.6. Fundus camera
      • 4.3.6.1. Market size and forecast
    • 4.3.7. Ophthalmoscopes
      • 4.3.7.1. Market size and forecast
    • 4.3.8. Optical coherence tomography systems
      • 4.3.8.1. Market size and forecast
    • 4.3.9. Perimeters
      • 4.3.9.1. Market size and forecast
    • 4.3.10. Slit lamps
      • 4.3.10.1. Market size and forecast
    • 4.3.11. Tonometer
      • 4.3.11.1. Market size and forecast
  • 4.4. Vision care devices
    • 4.4.1. Key market trends, growth factors, and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Contact lenses
      • 4.4.3.1. Market size and forecast
    • 4.4.4. Spectacle lenses
      • 4.4.4.1. Market size and forecast

CHAPTER 5: OPHTHALMIC DEVICES MARKET, BY REGION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. North America
    • 5.2.1. Key market trends, growth factors, and opportunities
    • 5.2.2. Market size and forecast, by product function
    • 5.2.3. Market size and forecast, by region
    • 5.2.4. U.S.
      • 5.2.4.1. Market size and forecast, by product function
    • 5.2.5. Canada
      • 5.2.5.1. Market size and forecast, by product function
    • 5.2.6. Mexico
      • 5.2.6.1. Market size and forecast, by product function
  • 5.3. Europe
    • 5.3.1. Key market trends, growth factors, and opportunities
    • 5.3.2. Market size and forecast, by product function
    • 5.3.3. Market size and forecast, by region
    • 5.3.4. Germany
      • 5.3.4.1. Market size and forecast, by product function
    • 5.3.5. France
      • 5.3.5.1. Market size and forecast, by product function
    • 5.3.6. UK
      • 5.3.6.1. Market size and forecast, by product function
    • 5.3.7. Italy
      • 5.3.7.1. Market size and forecast, by product function
    • 5.3.8. Spain
      • 5.3.8.1. Market size and forecast, by product function
    • 5.3.9. Rest of the Europe
      • 5.3.9.1. Market size and forecast, by product function
  • 5.4. Asia-Pacific
    • 5.4.1. Key market trends, growth factors, and opportunities
    • 5.4.2. Market size and forecast, by product function
    • 5.4.3. Market size and forecast, by region
    • 5.4.4. Japan
      • 5.4.4.1. Market size and forecast, by product function
    • 5.4.5. China
      • 5.4.5.1. Market size and forecast, by product function
    • 5.4.6. Australia market size and forecast
      • 5.4.6.1. Market size and forecast, by product function
    • 5.4.7. India
      • 5.4.7.1. Market size and forecast, by product function
    • 5.4.8. Rest of Asia-Pacific
      • 5.4.8.1. Market size and forecast, by product function
  • 5.5. LAMEA
    • 5.5.1. Key market trends, growth factors, and opportunities
    • 5.5.2. Market size and forecast, by product function
    • 5.5.3. Market size and forecast, by region
    • 5.5.4. Brazil
      • 5.5.4.1. Market size and forecast, by product function
    • 5.5.5. Saudi Arabia market size and forecast
      • 5.5.5.1. Market size and forecast, by product function
    • 5.5.6. South Africa
      • 5.5.6.1. Market size and forecast, by product function
    • 5.5.7. Rest of LAMEA
      • 5.5.7.1. Market size and forecast, by product function

CHAPTER 6: COMPANY PROFILES

  • 6.1. Carl Zeiss Meditec AG
    • 6.1.1. Company overview
    • 6.1.2. Company snapshot
    • 6.1.3. Operating business segments
    • 6.1.4. Product portfolio
    • 6.1.5. Business performance
    • 6.1.6. Key strategic moves and developments
  • 6.2. Essilor International S.A.
    • 6.2.1. Company overview
    • 6.2.2. Company snapshot
    • 6.2.3. Operating business segments
    • 6.2.4. Product portfolio
    • 6.2.5. Business performance
    • 6.2.6. Key strategic moves and developments
  • 6.3. Haag-Streit holding Ag
    • 6.3.1. Company overview
    • 6.3.2. Company snapshot
    • 6.3.3. Operating business segments
  • 6.4. Hoya Corporation
    • 6.4.1. Company overview
    • 6.4.2. Company snapshot
    • 6.4.3. Operating business segments
    • 6.4.4. Business performance
    • 6.4.5. Key strategic moves and developments
  • 6.5. Johnson & Johnson
    • 6.5.1. Company overview
    • 6.5.2. Company snapshot
    • 6.5.3. Operating business segments
    • 6.5.4. Product portfolio
    • 6.5.5. Business performance
    • 6.5.6. Key strategic moves and developments
  • 6.6. NIDEK CO., LTD.
    • 6.6.1. Company overview
    • 6.6.2. Company snapshot
    • 6.6.3. Operating business segments
    • 6.6.4. Key strategic moves & developments
  • 6.7. Novartis AG (ALCON-a division of Novartis)
    • 6.7.1. Company overview
    • 6.7.2. Company snapshot
    • 6.7.3. Operating business segments
    • 6.7.4. Product portfolio
    • 6.7.5. Business performance
  • 6.8. Topcon Corporation
    • 6.8.1. Company overview
    • 6.8.2. Company snapshot
    • 6.8.3. Operating business segments
    • 6.8.4. Product portfolio
    • 6.8.5. Business performance
  • 6.9. Bausch Health Companies Inc.
    • 6.9.1. Company overview
    • 6.9.2. Company snapshot
    • 6.9.3. Operating business segments
    • 6.9.4. Product portfolio
    • 6.9.5. Business performance
  • 6.10. Ziemer Ophthalmic Systems AG
    • 6.10.1. Company overview
    • 6.10.2. Company snapshot
    • 6.10.3. Product portfolio
  • 6.11. List of mergers and acquisitions (M&A) activities
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.